Is HPV Vaccination Still Worth It If You're Older?

7 hours ago

7 min read

中文摘要在文末

This question comes up constantly, usually phrased apologetically — as though there's an obvious answer and the person asking has missed it.

There isn't an obvious answer. It's a genuine judgement call, and it depends on you. Here's how to think about it.

The honest starting point

Protection is highest in people vaccinated before any sexual activity, and before around age 18.

That's the population where the vaccine performs best, and it's the reason programmes worldwide target adolescents. Nobody should tell you otherwise.

The benefit reduces with age, and with sexual activity. Both, and for related reasons.

Being older means less remaining lifetime during which new infection could occur and progress. Having been sexually active means you may already have been exposed to some of the types the vaccine covers — and vaccination does nothing about an exposure that has already happened. It prevents new infection; it doesn't clear existing infection or reverse past exposure.

So if you're 35 and someone tells you this will protect you exactly as it protects a 12-year-old, that isn't accurate.

But "reduced" is not "zero"

Here's the other half, and it's the part people miss.

Gardasil-9 covers nine HPV types. Having been sexually active does not mean you've encountered all nine. Most people who've been exposed to HPV have encountered one or two types, not the full set. Vaccination can still protect against the ones you haven't met.

Future exposure is still possible. New relationships happen. Circumstances change. Protection against types you haven't yet encountered still has value going forward.

So the realistic framing isn't "worth it" versus "pointless." It's that the expected benefit sits somewhere on a scale, higher when you're younger and have had fewer partners, lower when you're older and have had more — but not zero in most situations.

So how do you actually decide?

It's individualised. Which sounds like a dodge, so let me be concrete about the factors.

Things that push towards worthwhile:

You're at the younger end of adulthood
You've had few or no sexual partners
You anticipate new partners in future
You missed the school programme and would have been vaccinated if circumstances had been different
Cost isn't a significant barrier for you

Things that push the other way:

You're older
You've had many partners over a long period
Cost is a real strain
You'd be choosing between this and something else that matters more to your health

And one factor that isn't about the medicine at all: cost.

Gardasil-9 is not a cheap vaccine, and adults starting at 15 or older need three doses. That total is significant money for most households.

Our position is that if cost isn't a problem for you, the protection is worth having even where the expected benefit is more modest. But if it is a problem, that's a legitimate reason to decide against it, and there's nothing wrong with saying so.

What we'd rather you didn't do is quietly not proceed because you feel awkward raising cost. Raise it. It's a normal part of a medical decision.

If you missed the school programme

This is a large group, and it's worth calling out specifically.

Around 225,000 girls nationally missed doses or ended up with incomplete courses during the school closures of 2020 and 2021. They're now in their late teens and early twenties — which is exactly the age range where the remaining benefit is still substantial.

If that's you, you're in a genuinely good position to catch up. You may not have been sexually active yet, or not extensively, and you have a lot of remaining lifetime. The calculation looks much more like an adolescent's than a 40-year-old's.

And if you started the course and never finished — very common — bring whatever record you have. You usually won't need to start again from the beginning.

We don't run a formal catch-up programme, but we do catch-up doses when someone needs them.

What about men?

HPV isn't only a women's health issue. It causes genital warts in both sexes and is implicated in cancers that affect men.

The same logic applies: highest benefit before sexual activity, reducing with age and exposure, not zero.

Most of our HPV patients are female — that reflects how the vaccine has been publicised in Malaysia more than anything clinical. If you're male and want to discuss it, we're happy to.

Whatever you decide, screening still applies

If you're a woman, this is more important than the vaccination decision itself.

Vaccination does not replace cervical screening. Nine types is not all types, and vaccination does nothing about exposure that predates it. This is especially true if you're vaccinated as an adult, because the chance of prior exposure is higher.

So the worst possible outcome of reading this article would be someone getting vaccinated at 35, feeling reassured, and skipping screening for a decade. That would leave them worse off than if they'd never been vaccinated and simply attended screening.

Current Malaysian guidance recommends HPV testing for sexually active women aged 30 to 49, and Pap smear screening for women aged 21 to 29 and 50 to 65 — though more than one Ministry of Health document covers this and the bands aren't described identically, so confirm the current recommendation with whoever provides your screening. We don't provide screening at this clinic — we'll tell you where to go, and there's a separate article on it.

If you take one thing from this page: get screened regardless of what you decide about the vaccine.

Come and talk it through

We're happy to have this conversation without any expectation that you'll proceed. Tell us your age, roughly your history, and your circumstances, and we'll give you a straight assessment of what the vaccine is likely to be worth for you specifically — including if the answer is "probably not much."

WhatsApp 017-234 7328. Klinik Dr Tan, Lot 27, Ground Floor, Block D, Lintas Square, Kota Kinabalu. Appointments preferred.

Bring any vaccination records, particularly if you've had doses before.

A note on what this article is. General information based on current evidence and Malaysian guidance, not personalised medical advice. Whether HPV vaccination is appropriate for you depends on your individual circumstances.

简要说明

亚庇 Lintas Square 的 Klinik Dr Tan。

这个问题常有人问，而且通常问得很不好意思，好像有个显而易见的答案。其实没有。这是真正需要个别判断的问题。

诚实的起点：保护力在「未发生性行为、约 18 岁以前」接种的人身上最高。 这是全球计划都针对青少年的原因。保护效益会随年龄增长和性行为经验而下降——年纪较大表示剩余的可能感染并进展的时间较短；有过性行为表示可能已接触过疫苗涵盖的某些型别，而疫苗对已经发生的接触无能为力。

但「降低」不等于「零」：

Gardasil-9 涵盖九种型别。 有过性行为不代表九种都接触过——多数接触过 HPV 的人只遇过一两种，疫苗仍可保护你还没遇到的型别。
未来仍可能有新的接触。 新的关系、改变的处境，往后的保护仍有价值。

所以实际的框架不是「值得」对「白费」，而是效益落在一个光谱上：年轻、伴侣数少时较高；年长、伴侣数多时较低——但在多数情况下不是零。

怎么决定？

倾向值得的因素：年龄偏轻、性伴侣少或没有、预期未来会有新伴侣、当年错过学校计划、费用不构成负担。

倾向不值得的因素：年龄较大、长期有多位伴侣、费用是实际压力、这笔钱有更重要的健康用途。

还有一个与医学无关的因素：费用。 Gardasil-9 不便宜，而 15 岁以后开始需要三剂，总额对多数家庭是一笔实在的支出。

我们的立场：如果费用对你不构成问题，即使预期效益较温和，这份保护仍然值得。 但如果费用是负担，那是合理的不接种理由，直说无妨。我们最不希望的是你因为不好意思谈钱而默默放弃。

如果你错过了学校计划：全国约有 22.5 万名女生在 2020–2021 年学校关闭期间漏打或未完成疗程，她们现在多在十几二十岁——正是剩余效益仍然相当可观的年龄。你可能还没有性行为、或经验不多，而且剩余人生很长，这个计算比较接近青少年而非四十岁族群。

如果你开始了但没打完（很常见），请带上任何记录，通常不需要从头开始。我们不设正式补种计划，但需要补打时我们可以处理。

男性呢？ HPV 不只是女性健康议题，它在两性都造成生殖器疣，也与男性会罹患的癌症有关。同样的逻辑适用。我们的 HPV 病人以女性居多，那反映的是马来西亚的宣传方式，而非临床上的差别。

不论你的决定是什么，筛检仍然适用——对女性来说，这比接种与否更重要。

接种不能取代子宫颈筛检。 九种不是全部，而且疫苗对接种前已发生的接触无效。成人接种时更是如此，因为先前接触的机率更高。

读完这篇文章最糟的结果，就是有人在 35 岁接种、感到安心、然后十年不做筛检——那会让她比从没接种但有定期筛检更糟。

马来西亚现行指引建议：30 至 49 岁有性行为的女性做 HPV 检测；21 至 29 岁及 50 至 65 岁做子宫颈抹片。（卫生部有不只一份相关文件，年龄分组的描述并不完全一致，请向筛检提供者确认目前的建议。）本诊所不提供筛检，我们会告诉你去哪里做，另有专文说明。